SCHEMBL4926318

SCHEMBL4926318

c1ccc(C(=NNc2ccccn2)c2ccccn2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.72
KDM6B O15054 1/20 0.72
TET3 O43151 1/20 0.72
KDM4A O75164 1/20 0.72
KDM4B O94953 1/20 0.72
KDM5A P29375 1/20 0.72
KDM5C P41229 1/20 0.72
KDM4D Q6B0I6 1/20 0.72
TET2 Q6N021 1/20 0.72
TET1 Q8NFU7 1/20 0.72
KDM4C Q9H3R0 1/20 0.72
KDM5B Q9UGL1 1/20 0.72
KMT2A Q03164 5/20 0.65
MEN1 O00255 4/20 0.65
GAA P10253 4/20 0.65
HPGD P15428 3/20 0.65
ALOX12 P18054 1/20 0.65
AGTR1 P30556 4/20 0.61
ALDH1A1 P00352 4/20 0.58
CYP1A2 P05177 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20101080 1.00 KDM4E (0.72) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL15267189 0.90 KDM4E (0.58) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL20101083 0.87 KDM4E (0.64) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL18292348 0.85 KMT2A (0.81) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL29353093 0.84 KDM4E (1.00) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL17670545 0.84 KDM4E (1.00) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL18159120 0.84 KDM4E (0.73) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL20101032 0.84 KDM4E (0.58) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL20214000 0.84 KDM4E (1.00) KDM4EKDM6BTET3KDM4AKDM4B
SCHEMBL29382353 0.84 KDM4E (1.00) KDM4EKDM6BTET3KDM4AKDM4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140171635-A1 NOVEL HYDRAZONE-BASED AND OXIME-BASED FLUORESCENT AND CHROMOPHORIC/PRO-FLUORESCENT AND PRO-CHROMOPHORIC REAGENTS AND LINKERS SOLULINK BIOSCIENCES, INC. (US) 2014-06-19 US disclosed
US-8541555-B2 Hydrazone-based and oxime-based fluorescent and chromophoric/pro-fluorescent and pro-chromophoric reagents and linkers SOLULINK BIOSCIENCES, INC. (US) 2013-09-24 US disclosed
US-20080221343-A1 Labeled biomolecules of chromophore or the fluorophore incorporated into the linker between a reactive linking moiety and a biotin molecule; proteins, nucleic acids AUDAX PRIVATE DEBT LLC, AS AGENT 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221343-A1 Labeled biomolecules of chromophore or the fluorophore incorporated into the linker between a reactive linking moiety and a biotin molecule; proteins, nucleic acids RRP12, MRPS22, HBG2 KDM4E 4479/4885KDM6B 4156/4885TET3 2464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.